Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 13376 - 13400 of 14792 in total
MVA3000 is an attenuated smallpox vaccine that is being developed for use in people for whom the traditional smallpox vaccine is contraindicated, such as patients with disorders of the immune system or skin conditions such as eczema.
Investigational
Matched Description: … people for whom the traditional smallpox vaccine is contraindicated, such as patients with disorders of
IGN301 is a cancer vaccine based on an anti-idiotypic antibody which provokes an immune response to Lewis Y. Lewis Y is a carbohydrate molecule expressed on the surface of tumor cells of epithelial origin (e.g. lung, intestinal, breast, prostate or ovarian cancers).
Investigational
Matched Description: … Lewis Y is a carbohydrate molecule expressed on the surface of tumor cells of epithelial origin (e.g. …
NUC B1000 is an expressed interfering RNA (eiRNA)- based product consisting of a plasmid DNA construct designed to produce four short interfering RNA (siRNA) molecules, formulated with a proprietary cationic-lipid delivery system. eiRNA is an approach to RNAi therapeutics, whereby a plasmid DNA coding for desired dsRNA is delivered to...
Investigational
Matched Description: … NUC B1000 is an expressed interfering RNA (eiRNA)- based product consisting of a plasmid DNA construct ... On January 11, 2008, it was announced that NUC B1000 was entering a phase 1 human safety study of its …
IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.
Investigational
Matched Description: … It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. ... It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from …
TA-CIN is a subunit vaccine comprising L2/E6/E7 proteins from Human Papillomavirus (HPV16), designed to generate a strong cellular immune response against HPV-infected cells.
Investigational
HSV-2 theracine is an attenuated recombinant vaccine developed by AuRx for the treatment of genital herpes.
Investigational
Matched Description: … HSV-2 theracine is an attenuated recombinant vaccine developed by AuRx for the treatment of genital herpes …
Q-Derp1 is developed by Cytos Biotechnology as an immunodrug. It is an antigen for the prevention of various major chronic diseases. Derp1 is the dominant allergic protein found in dust mite feces.
Investigational
Matched Description: … It is an antigen for the prevention of various major chronic diseases. …
TRX1 is a humanized antibody that binds to the CD4 receptor found on a subset of T cells. TRX1 is being developed for the potential treatment of autoimmune diseases in collaboration with Genentech, Inc. TolerRx is currently conducting a Phase I clinical study of TRX1 in the United Kingdom.
Investigational
Matched Description: … TRX1 is a humanized antibody that binds to the CD4 receptor found on a subset of T cells. ... TolerRx is currently conducting a Phase I clinical study of TRX1 in the United Kingdom. ... TRX1 is being developed for the potential treatment of autoimmune diseases in collaboration with Genentech …
Investigational
Experimental
Placulumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Placulumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.
Investigational
Matched Description: … Glucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome. …
Denenicokin is under investigation in clinical trial NCT01152788 (Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma).
Investigational
Matched Description: … Denenicokin is under investigation in clinical trial NCT01152788 (Phase II Study of Interleukin-21 (rIL …
Disitertide has been used in trials studying the treatment of Skin Fibrosis.
Investigational
Matched Description: … Disitertide has been used in trials studying the treatment of Skin Fibrosis. …
Experimental
Investigational
Ingredient used in over-the-counter medications.
Experimental
Sus scrofa placenta is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Pearl (hyriopsis cumingii) is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Displaying drugs 13376 - 13400 of 14792 in total